patient selection for car-t in all
Published 3 years ago • 86 plays • Length 1:33Download video MP4
Download video MP3
Similar videos
-
1:52
perspectives on patient selection for car-t therapy
-
3:07
the role of bridging and timing in car-t
-
2:34
safety considerations in car-t therapy: patient selection and side effects
-
2:20
car t-cell therapy access and reimbursement: the patient's perspective
-
1:49
a novel subcutaneous car-t therapy for the treatment of hematological malignancies
-
1:37
could car-t potentially replace asct in ndmm?
-
1:06
car-t cell therapy: current applications and how to improve treatment strategies in the future
-
3:14
car t-cell therapy explained (manufacturing process & how it works)
-
9:25
mgus diagnosis: a step-by-step approach
-
2:54
mediating the high expense of car t-cell therapy
-
1:13
monitoring patients with cll on ibrutinib-based therapies
-
1:16
the efficacy of car t-cell therapy in richter's transformation
-
4:17
preparing for the commercialization of car-t products
-
2:30
car-t as a new standard of care in lymphoma
-
3:21
practical considerations for car-t therapy in lymphoma
-
1:38
challenges of car-t therapy in the real-world setting
-
3:08
car t-cell therapy: the patient's perspective
-
1:25
the impact of car-t therapy on patient care
-
1:55
unmet needs in dlbcl: frontline therapy, car-t optimization, and clinical trial inclusion
-
3:43
the future of car-t therapy
-
0:35
the importance of patient monitoring post-car-t treatment